Extra oxygen treatment in a pressure chamber after leg or foot amputation
Tests hyperbaric oxygen therapy after lower limb amputation in adults with diabetes or poor circulation.
Key facts
- Who runs it
- Oslo University Hospital
- Where
- Norway2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Additional Hyperbaric Oxygen After Lower Extremity Amputation
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 4 Jul 2018
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Hyperbaric oxygen therapy
- Record updated
- 30 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had a leg or foot amputation because of a long-lasting wound, bone infection (osteomyelitis), poor blood flow or dead tissue. They will get either hyperbaric oxygen therapy (breathing pure oxygen in a pressure chamber) or standard care.
- Age
- 18 Years to 90 Years
- Sex
- All sexes can join.
- Disease stage
- Lower leg or foot amputation because of a chronic wound, osteomyelitis, ischemia (poor blood flow) or necrosis (dead tissue). People must join within 7 days after their final surgery.
- Earlier treatment
- Must have had a lower extremity amputation. An anesthesiologist or hyperbaric medicine doctor must find them fit to receive hyperbaric oxygen therapy.
Main reasons for not taking part
- Pregnancy
- Dementia
- Not able to cooperate and attend follow-up appointments
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis
- Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician
- Able to cooperate and follow up appointments
- Included within 7 days after final surgery
Who cannot take part
- Dementia
- Not fulfilling inclusion criteria
- Pregnancy
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.
The 2 groups in the trial
- Hyperbaric oxygen therapyTreatment being tested
30 sessions of Hyperbaric oxygen therapy, 90min treatment at 2,4 ATA(atmosphere absolute) with 100% oxygen.First session must be given within 7 days after initial amputation. Treatment is given as outpatient treatment after discharge from hospital.
- Control groupNo study treatment, for comparison
Control group will be given standard of care with follow up at the outpatient clinic after discharge from hospital.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial
- Plain-language title
- Extra oxygen treatment in a pressure chamber after leg or foot amputationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT03594344, who can take part
- Record updated
- 30 March 2025